(SABR) Sabre Corpo - Overview
Stock: Reservation System, Travel Marketplace, SaaS Solutions, Hotel Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 75.0% |
| Relative Tail Risk | -18.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.08 |
| Alpha | -93.63 |
| Character TTM | |
|---|---|
| Beta | 1.905 |
| Beta Downside | 1.358 |
| Drawdowns 3y | |
|---|---|
| Max DD | 80.50% |
| CAGR/Max DD | -0.40 |
Description: SABR Sabre Corpo January 18, 2026
Sabre Corporation (NASDAQ:SABR) is a global travel-technology provider operating two divisions: Travel Solutions, which runs a B2B marketplace aggregating airline, hotel, car-rental, rail, cruise and tour-operator inventory for agencies, TMCs and corporate travel departments, and delivers SaaS reservation and revenue-management systems (including the SabreMosaic retailing platform) to airlines; and Hospitality Solutions, which supplies SaaS and hosted software to hotels. The company, incorporated in 2006 and headquartered in Southlake, Texas, is classified under the Data Processing & Outsourced Services sub-industry.
Key recent metrics: FY 2023 revenue was approximately $2.4 billion, with SaaS recurring revenue growing ~12% YoY and adjusted EBITDA margin hovering around 10%. Sabre’s market share in airline reservation systems remains near 30%, trailing only Amadeus and Travelport, and its free-cash-flow generation has improved as airlines accelerate digital transformation post-COVID. Macro drivers include the rebound in discretionary travel spending, airline consolidation that fuels demand for integrated revenue-management tools, and the broader industry shift toward cloud-based, data-intelligent platforms.
For a deeper quantitative assessment, you may find ValueRay’s analyst dashboards useful for tracking Sabre’s valuation trends and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -247.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -5.93 > 1.0 |
| NWC/Revenue: 4.81% < 20% (prev 0.78%; Δ 4.03% < -1%) |
| CFO/TA -0.04 > 3% & CFO -184.6m > Net Income -247.6m |
| Net Debt (3.53b) to EBITDA (329.0m): 10.74 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (429.3m) vs 12m ago 11.28% < -2% |
| Gross Margin: 37.28% > 18% (prev 0.29%; Δ 3699 % > 0.5%) |
| Asset Turnover: 63.83% > 50% (prev 62.42%; Δ 1.41% > 0%) |
| Interest Coverage Ratio: 0.30 > 6 (EBITDA TTM 329.0m / Interest Expense TTM 479.7m) |
Altman Z'' -3.08
| A: 0.03 (Total Current Assets 1.16b - Total Current Liabilities 1.02b) / Total Assets 4.37b |
| B: -0.85 (Retained Earnings -3.70b / Total Assets 4.37b) |
| C: 0.03 (EBIT TTM 145.9m / Avg Total Assets 4.53b) |
| D: -0.71 (Book Value of Equity -3.77b / Total Liabilities 5.31b) |
| Altman-Z'' Score: -3.08 = D |
Beneish M -3.30
| DSRI: 0.95 (Receivables 384.1m/408.7m, Revenue 2.89b/2.93b) |
| GMI: 0.78 (GM 37.28% / 29.04%) |
| AQI: 0.98 (AQ_t 0.68 / AQ_t-1 0.69) |
| SGI: 0.99 (Revenue 2.89b / 2.93b) |
| TATA: -0.01 (NI -247.6m - CFO -184.6m) / TA 4.37b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of SABR shares?
Over the past week, the price has changed by -14.29%, over one month by -21.92%, over three months by -39.36% and over the past year by -67.05%.
Is SABR a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SABR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.5 | 115.8% |
| Analysts Target Price | 2.5 | 115.8% |
| ValueRay Target Price | 0.8 | -30.7% |
SABR Fundamental Data Overview February 03, 2026
P/S = 0.1692
P/B = 145.0984
P/EG = 1.3572
Revenue TTM = 2.89b USD
EBIT TTM = 145.9m USD
EBITDA TTM = 329.0m USD
Long Term Debt = 4.06b USD (from longTermDebt, last quarter)
Short Term Debt = 153.0m USD (from shortTermDebt, last quarter)
Debt = 4.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.53b USD (from netDebt column, last quarter)
Enterprise Value = 4.05b USD (513.4m + Debt 4.22b - CCE 682.7m)
Interest Coverage Ratio = 0.30 (Ebit TTM 145.9m / Interest Expense TTM 479.7m)
EV/FCF = -15.56x (Enterprise Value 4.05b / FCF TTM -260.1m)
FCF Yield = -6.43% (FCF TTM -260.1m / Enterprise Value 4.05b)
FCF Margin = -8.99% (FCF TTM -260.1m / Revenue TTM 2.89b)
Net Margin = -8.56% (Net Income TTM -247.6m / Revenue TTM 2.89b)
Gross Margin = 37.28% ((Revenue TTM 2.89b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 56.22% (prev 31.77%)
Tobins Q-Ratio = 0.93 (Enterprise Value 4.05b / Total Assets 4.37b)
Interest Expense / Debt = 2.64% (Interest Expense 111.2m / Debt 4.22b)
Taxrate = 21.0% (US default 21%)
NOPAT = 115.3m (EBIT 145.9m * (1 - 21.00%))
Current Ratio = 1.14 (Total Current Assets 1.16b / Total Current Liabilities 1.02b)
Debt / Equity = -4.36 (negative equity) (Debt 4.22b / totalStockholderEquity, last quarter -966.5m)
Debt / EBITDA = 10.74 (Net Debt 3.53b / EBITDA 329.0m)
Debt / FCF = -13.59 (negative FCF - burning cash) (Net Debt 3.53b / FCF TTM -260.1m)
Total Stockholder Equity = -1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.46% (Net Income -247.6m / Total Assets 4.37b)
RoE = 16.56% (negative equity) (Net Income TTM -247.6m / Total Stockholder Equity -1.49b)
RoCE = 5.68% (EBIT 145.9m / Capital Employed (Equity -1.49b + L.T.Debt 4.06b))
RoIC = 3.43% (NOPAT 115.3m / Invested Capital 3.36b)
WACC = 3.26% (E(513.4m)/V(4.73b) * Re(12.93%) + D(4.22b)/V(4.73b) * Rd(2.64%) * (1-Tc(0.21)))
Discount Rate = 12.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.35%
Fair Price DCF = unknown (Cash Flow -260.1m)
EPS Correlation: 87.65 | EPS CAGR: 44.63% | SUE: 1.63 | # QB: 1
Revenue Correlation: 67.06 | Revenue CAGR: 9.98% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.06 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.21 | Chg30d=-0.003 | Revisions Net=-1 | Growth EPS=+528.6% | Growth Revenue=+3.9%